Ruzanna Papyan on Neuroblastoma Risk Stratification in Real-World Settings
Ruzanna Papyan, Chief of Pediatric Oncology Department at PCBDC, Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia, shared on LinkedIn:
”Check out our new article, “Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries,” that has just been just published!
This work reflects a truly international collaboration and a shared commitment to adapting neuroblastoma risk stratification to real-world settings.
Read the article here.
Grateful for the collaboration, the shared vision, and the ongoing efforts to improve outcomes for children with neuroblastoma globally”
Article: Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project
Authors: Wendy London, Gabriela Villanueva, Derek Shyr, Jaques van Heerden, Soad Fuentes-Alabi, Raya Saab, Derek Harrison, Ruzanna Papyan, Hoa Thi Kim Nguyen, Dolly Noun, Joyce Kambugu, Jelena Rascon, Miklos Garami, Dongjing Guo, Paige Kao, Arlene Naranjo, Julie R. Park, Susan L. Cohn, Carlos Rodriguez-Galindo, Katherine K. Matthay
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 13:53Steven Lubega: Why Are Healthy Newborns Born Poorly Equipped To Stop Bleeding?
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa
-
Aug 11, 2026, 13:34Brett Hoover: Plaque Burden May Be Key to Predicting MACE Risk
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC